Hepatocellular carcinoma surveillance: The road ahead

Ruben Hernaez^{1

2}, Hashem B El-Serag^{1

2}

Affiliations

¹ Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, TX.
² Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX.

Editorial

Ruben Hernaez et al. Hepatology. 2017 Mar.

. 2017 Mar;65(3):771-773.

doi: 10.1002/hep.28983. Epub 2017 Jan 31.

Ruben Hernaez^{1

2}, Hashem B El-Serag^{1

2}

¹ Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, TX.
² Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX.

No abstract available

Comment on

Identifying barriers to hepatocellular carcinoma surveillance in a national sample of patients with cirrhosis.
Goldberg DS, Taddei TH, Serper M, Mehta R, Dieperink E, Aytaman A, Baytarian M, Fox R, Hunt K, Pedrosa M, Pocha C, Valderrama A, Kaplan DE. Goldberg DS, et al. Hepatology. 2017 Mar;65(3):864-874. doi: 10.1002/hep.28765. Epub 2016 Oct 5. Hepatology. 2017. PMID: 27531119
Patient-reported barriers are associated with lower hepatocellular carcinoma surveillance rates in patients with cirrhosis.
Farvardin S, Patel J, Khambaty M, Yerokun OA, Mok H, Tiro JA, Yopp AC, Parikh ND, Marrero JA, Singal AG. Farvardin S, et al. Hepatology. 2017 Mar;65(3):875-884. doi: 10.1002/hep.28770. Epub 2016 Oct 1. Hepatology. 2017. PMID: 27531684 Free PMC article.
The underreporting of hepatocellular carcinoma to the cancer register and a log-linear model to estimate a more correct incidence.
Törner A, Stokkeland K, Svensson Å, Dickman PW, Hultcrantz R, Montgomery S, Duberg AS. Törner A, et al. Hepatology. 2017 Mar;65(3):885-892. doi: 10.1002/hep.28775. Epub 2016 Sep 30. Hepatology. 2017. PMID: 27533761